Fontana, Pierre

 
Title Year Hits Downloads
A focus on the role of platelets in liver regeneration: do platelet-endothelial cell interactions initiate the regenerative process? 2015 260 0
A multicenter study to assess the reproducibility of antiphospholipid antibody results produced by an automated system 2017 133 3
Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels 2017 79 0
Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance 2009 180 0
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 2014 275 1
Angiologie et hémostase 2017 89 37
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis 2016 305 140
Antiagregants plaquettaires : lequel, quand et pour qui ? 2010 216 0
Anticoagulants oraux directs (ACOD) : une aide à la prescription dans la pratique quotidienne 2016 76 18
Antiplaquettaires et patients âgés : quelles molécules et quelles preuves ? 2013 237 1
Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study 2012 288 3
Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies? 2015 290 1
Antiplatelet Therapy: Targeting the TxA2 Pathway 2014 238 2
Aspirin "resistance" and risk of cardiovascular morbidity 2008 211 1
Aspirin for venous thromboembolism prevention and treatment: a renewal? 2012 238 99
Aspirin response variability assessed with the PFA-100 device 2008 250 0
Aspirin response: Differences in serum thromboxane B2 levels between clinical studies 2016 265 1
Aspirin-mediated acetylation of haemoglobin increases in presence of high glucose concentration and decreases protein glycation 2015 112 74
Assessing aspirin responsiveness using the Verify Now Aspirin assay 2008 262 1
Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness 2008 223 0
Cell-derived microparticles in haemostasis and vascular medicine 2009 224 0
Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins 2015 302 1
Characterization of the platelet granule proteome: Evidence of the presence of MHC1 in alpha-granules 2014 363 3
Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis 2010 177 0
Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study 2010 235 0
Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach 2016 184 116
Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring 2017 96 10
Connexin 37 limits thrombus propensity by downregulating platelet reactivity 2011 310 408
Correction of prasugrel-related bleeding by prophylactic transfusion of human platelets in a rabbit model 2016 119 2
Diagnosis of mild bleeding disorders 2009 289 924
Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism 2014 253 128
Direct oral anticoagulants: a guide for daily practice 2016 330 142
Direct oral anticoagulants: efficacy and safety in patient subgroups 2015 322 178
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients? 2017 91 0
Effect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled study 2016 126 0
Effects of plasma transfusions on antithrombin levels after paediatric liver transplantation 2018 45 0
Evaluation de l'efficacité biologique du clopidogrel: génotype ou phénotype? 2010 193 0
Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit model 2018 103 4
Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: An observational study on cord blood 2014 195 2
Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review 2015 252 4
Fibrin degradation during sonothrombolysis – Effect of ultrasound, microbubbles and tissue plasminogen activator 2015 227 0
Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A. 2014 262 3
Functional role of a polymorphism in the Pannexin1 gene in collagen-induced platelet aggregation 2015 191 8
Genetic testing to identify women at risk of venous thromboembolism with contraceptive pills: Evidence or hope-based tool ? 2016 180 60
Genetics of clopidogrel poor-response 2016 151 0
Gestes invasifs et patients sous anticoagulants oraux : to bridge or not to bridge ? 2013 253 1
Gestion péri-interventionnelle des nouveaux agents antiplaquettaires 2013 269 140
Hémostase : nouveaux anticoagulants oraux : de la théorie à la pratique 2013 100 0
Hémostase. Aspirine: une ou deux fois par jour? 2014 293 2
Hémostase. Le point sur les nouveaux antithrombotiques 2010 238 0
How to manage prasugrel and ticagrelor in daily practice 2014 121 90
Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study 2017 78 0
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites 2018 31 9
Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability 2010 278 0
Impact of high glucose concentration on aspirin-induced acetylation of human serum albumin: An in vitro study 2014 110 31
Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study 2015 213 0
Impact of pneumatic tube system transport for the monitoring of heparin therapy 2017 83 0
Impact of rivaroxaban on point-of-care assays 2017 106 0
Impending paradoxical embolism. When and how to treat? 2008 255 1
Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis 2012 242 0
Intercellular communication in atherosclerosis 2009 247 0
La maladie thromboembolique veineuse : une pathologie souvent oubliée 2016 61 16
Laboratory testing of Hemostasis 2015 91 72
Laboratory-defined aspirin resistance and recurrent cardiovascular events 2008 239 0
Lack of Effect of Platelet Transfusions and Desmopressin on Intracranial Bleeding in a Patient Receiving Ticagrelor 2015 197 1
Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma 2015 148 101
Le concept de "resistance" a l'aspirine: mecanismes et pertinence clinique 2009 235 0
Le défi des maladies vasculaires rares : l’union fait la force ! 2017 11 3
Maladies cardiovasculaires, antiagrégants, anticoagulants et risque hémorragique 2010 252 0
Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT 2018 81 2
Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015 2017 130 0
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013 2013 194 0
Modulation of osteoblast behavior on TiNxOy coatings by altering the N/O stoichiometry while maintaining a high thrombogenic potential 2016 194 3
New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach 2016 264 6
News in angiology and hemostasis 2016 225 78
No influence of the VAMP8 rs1010 single nucleotide polymorphism on platelet functions in vitro 2009 216 0
Pannexin- and Connexin-Mediated Intercellular Communication in Platelet Function 2017 125 47
Pannexin1 Single Nucleotide Polymorphism and Platelet Reactivity in a Cohort of Cardiovascular Patients 2017 139 1
Pharmacogenomics of Oral Antithrombotic Drugs 2016 240 0
Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided? 2009 214 0
Platelet proteomics 2012 228 2
Platelet reactivity in stable cardiovascular patients with chronic kidney disease 2017 127 0
Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients 2011 271 1
Platelets in liver regeneration 2017 91 3
Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management 2012 252 0
PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients 2016 127 0
Prevalence of poor biological response to clopidogrel: a systematic review 2012 182 0
Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti-beta2 glycoprotein-1 antibodies 2014 237 0
Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study 2011 246 0
Reply to: "The role of platelets in liver regeneration - What don't we know?" 2015 119 0
Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect 2016 97 33
Role of paraoxonase-1 in CYP2C19 loss-of-function carriers 2014 263 0
Sputtered titanium oxynitride coatings for endosseous applications: Physical and chemical evaluation and first bioactivity assays 2014 346 1
Subthalamic nucleus deep brain stimulation for Parkinson's disease in a patient with severe haemophilia A. 2017 86 0
Surveillance biologique des héparines et du fondaparinux 2011 249 2
Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing? 2015 248 2
Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping 2013 169 0
The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin 2011 231 0
The Human Diabetes Proteome Project (HDPP): From network biology to targets for therapies and prevention 2013 254 17
The Human Diabetes Proteome Project (HDPP): The 2014 update 2015 153 78
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro 2012 199 0
Thromboses veineuses splanchniques 2017 19 3
Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management 2013 255 0
TiN x O y coatings facilitate the initial adhesion of osteoblasts to create a suitable environment for their proliferation and the recruitment of endothelial cells 2017 125 2
TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke 2016 127 0
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation 2017 94 0
Unraveling modulators of platelet reactivity incardiovascular patients using omics strategies: Towards anetwork biology paradigm 2013 267 222
Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants 2015 168 100
Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis 2008 270 1
Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data 2016 180 2
[Angiology and haemostasis. Highlights on some new data in 2017] 2018 12 2
21312 3450